Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9604 posts found.

New therapy offers triple threat to HIV virus

September 22, 2017 Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
News
crack_cocaine

Weight loss drugs could be used to treat cocaine addiction

September 21, 2017 Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical

Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …
News
novartis_side_building

Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis

September 20, 2017 Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …
News
bill_gates_-_world_economic_forum_annual_meeting_davos_2008_number2

Gates Foundation invest in Immunocore, warning of infectious disease threat

September 20, 2017 Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, infectious diseases, pharma, pharmaceutical

It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …
News
world_health_organization

Antibiotic development is inadequate to meet global resistance threat, WHO warns

September 20, 2017 Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization

The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …
News

BMS’ Opdivo to finally be made available to lung cancer patients in the UK

September 20, 2017 Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, biotech, drugs, opdivo, pharma, pharmaceutical

It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers …
News
gsk_hq_close

GSK gets FDA approval for key triple therapy inhaler

September 20, 2017 Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical

The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
News
acute_leukemia-all

Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint

September 19, 2017 Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical

Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …
News
janssen_latest_logo_on_sign_closer

Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab

September 19, 2017 Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals

Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …
News
diabetes-776999_960_720

Swine flu pandemic linked to increased incidence of diabetes

September 19, 2017 Manufacturing and Production, Research and Development biotech, diabetes type 1, drugs, influenza, pharma, pharmaceutical, swine flu

The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers …
News
scholar_rock_heather_faulds_headshot_bizwire

Scholar Rock prise Regulatory Affairs director away from Biogen

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scholar Rock, biotech, drugs, pharma, pharmaceutical

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …
Appointment
novartis_window

Novartis’ Xolair shows strong retreatment efficacy at Phase 3 in chronic spontaneous urticaria

September 18, 2017 Research and Development, Sales and Marketing Novartis, Xolair, chronic spontaneous urticarial, pharma, pharmaceutical

Novartis has released new data demonstrating the efficacy of Xolair (omalizumab) in the treatment of chronic spontaneous urticaria (CSU), a …
News
computer_and_doctor

Standing together: Supercharging the clinical trial in Europe

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical

The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …
News

Pfizer receives prostate cancer drug boost with trial results

September 15, 2017 Medical Communications, Research and Development Astellas, Pfizer, Xtandi, biotech, drugs, pharma, pharmaceutical

Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …
News
The Gateway to Local Adoption Series

Latest content

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026

Canada awards CSL Seqirus with influenza pandemic vaccine contract

March 17, 2026

Helus Pharma appoints Jill Conwell as Chief People Officer

March 16, 2026